Feedback / Questions
RGT-61159 - Rgenta Therap
https://www.globenewswire.com/news-release/2025/09/17/3151594/0/en/Rgenta-Therapeutics-Receives-Orphan-Drug-Designation-from-the-U-S-FDA-for-RGT-61159-for-the-Treatment-of-Adenoid-Cystic-Carcinoma-ACC.html
Sep 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next